The capex-meets-IP fact first: the 2nm story is sold as a transistor architecture but built from dozens of fine-grained process techniques. US11728340B2, granted August 2023 to IBM, patents single-diffusion-break isolation for gate-all-around (GAA) transistors (CPC H01L 27/0886).
Gloss it once. GAA transistors wrap the gate fully around the channel for better control at small sizes. "Single diffusion break" isolation is a way to separate adjacent transistors using a narrower break than older two-break schemes — which saves area. In a node where every square nanometer counts, isolation efficiency is a direct density lever.
Why a capex desk reads it: nodes get cheaper per transistor only if density improves, and density comes from exactly these incremental process techniques, not from the architecture alone. IBM is a research-and-IP powerhouse in logic process, and its grants map where the enabling techniques are being invented — often ahead of the foundries that license or independently develop them.
The period framing matters. In 2023, GAA was entering production at the leading foundries. IBM patenting GAA isolation at that moment reflects the deep, distributed IP base underneath the 2nm transition — the techniques that make the marketing node real.
The caveat we attach: a process patent is a defensive and licensing asset, not a node or a product. It evidences where a density technique was invented; it does not establish who ships it or at what yield.
For the period investor, the lesson is that node leadership is an accumulation of small process wins. A 2023 GAA isolation grant from IBM is one such win — the kind the headline never mentions but the node depends on.